Triphenylbromoethylene
| Clinical data | |
|---|---|
| Trade names | Bromylene, Eitriphin, Oestronyl, Prostilban, Tribenorm |
| Other names | TPBE; Tribromophenylethylene; Bromotriphenylethylene; Phenylstilbene bromide; Fenbrostilbenum |
| Drug class | Nonsteroidal estrogen |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.015.029 |
| Chemical and physical data | |
| Formula | C20H15Br |
| Molar mass | 335.244 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Triphenylbromoethylene (TPBE; brand names Bromylene, Eitriphin, Oestronyl, Prostilban, Tribenorm), also known as bromotriphenylethylene or as phenylstilbene bromide, is a synthetic nonsteroidal estrogen of the triphenylethylene group that was marketed in the 1940s similarly to the closely related estrogen triphenylchloroethylene.